Le site des Doctorants

De la Faculté de Médecine de l'ULB

Publis2003

 

 

La mise à jour de cette rubrique dépend de vous ! Envoyez-moi les références de vos publications.

doc7 This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 


Backers K, Blero D, Paternotte N, Zhang J, Erneux C.
The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.
Adv Enzyme Regulation 43, 15-28, 2003.

Bali E, Willermain F, Caspers-Velu L, Dubois C, Dehou MF, Velu T, Libert J, Bruyns C.
IL-10 in vivo gene expression in a cell- induced animal model of proliferative vitreoretinopathy.
Int J Mol Med 12, 305-310, 2003.

Blanpain C, Le Poul E, Parma J, Knoop C, Detheux M, Parmentier M, Vassart G, Abramowicz MJ.
Serotonin 5-HT(2B) receptor loss of function mutation in a patient with fenfluramine-associated primary pulmonary hypertension.
Cardiovasc Res 60, 518-528, 2003.

Blanpain C, Doranz BJ, Bondue A, Govaerts C, De Leener A, Vassart G, Doms RW, Proudfoot A, Parmentier M.
The core domain of chemokines bind CCR5 extracellular domains while their amino-terminus interacts with the transmembrane helix bundle.
J Biol Chem 278, 5179-5187, 2003.

Boeynaems JM, Wilkin F, Marteau F, Duhant X, Savi P, Suarez-Gonzalez N, Robaye B, Communi D.
P2Y receptors: New subtypes, new functions.
Drug Dev Res 59, 30-35, 2003.

Cabay L, Willermain F, Bruyns C, Verdebout JM, Witta Y, Baffi J, Velu T, Libert J, Caspers-Velu L, Maho A, Lespagnard L.
CXCR4 expression in vitreoretinal membranes.
Brit J Ophthalmol 87, 567-569, 2003.

Cheong SC, Clement N, Velu T, Brandenburger A.
A novel method for the titration of recombinant virus stocks by ELISPOT assay.
J Virol Meth 109, 119-124, 2003.

Chtarto A, Tenenbaum L, Velu T, Brotchi J, Levivier M, Blum D.
Minocycline-induced activation of tetracycline-responsive promoter.
Neurosci Lett 352, 155-158, 2003.

Chtarto A, Bender HU, Hanemann CO, Kemp T, Lehtonen E, Levivier M, Brotchi J, Velu T, Tenenbaum L.
Tetracycline-inducible transgene expression mediated by a single AAV vector.
Gene Ther 10, 84-94, 2003.

Clermont F, Adam E, Dumont JE, Robaye B.
Survival pathways regulating the apoptosis induced by tumour necrosis factor-alpha in primary cultured bovine endothelial cells.
Cell Signal 15, 539-546, 2003.

Coulonval K, Bockstaele L, Paternot S, Roger PP.
Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis.
J Biol Chem 278, 52052-52060, 2003.

Coulonval K, Bockstaele L, Paternot S, Dumont JE, Roger PP.
The cyclin D3-CDK4-p27(kip1) holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFO, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis.
Exp Cell Res 291, 135-149, 2003.

Dewaste V, Erneux C.
Inositol 1, 4, 5-trisphosphate 3-kinase and 5-phosphatase.
Handbook of Cell Signaling 2, 11-13, 2003.

Dewaste V, Moreau C, De Smedt F, Bex F, De Smedt H, Wuytack F, Missiaen L, Erneux C.
The three isoenzymes of human inositol-1, 4, 5-trisphosphate 3-kinase show specific intracellular localization but comparable Ca2+ responses on transfection in COS-7 cells.
Biochem J 374, 41-49, 2003.

Dremier S, Kopperud R, Doskeland SO, Dumont JE, Maenhaut C.
Search for new cyclic AMP-binding proteins.
FEBS Lett 546, 103-107, 2003.

Driessens G, Harsan L, Browaeys P, Giannakopoulos X, Velu T, Bruyns C.
Assessment of in vivo chemotherapy-induced DNA damage in a p53- mutated rat tumor by micronuclei assay.
Apoptosis: from Signaling Pathways to Therapeutic Tools. 1010, 775-779, 2003.

Driessens G, Harsan L, Robaye B, Waroquier D, Browaeys P, Dubois C, Gangji D, Velu T, Bruyns C.
Micronuclei assay is a sensitive method to detect in vivo chemotherapy-induced DNA-damage in a p53 mutated rat tumor.
Acta Clinica Belgica 58, 126-147, 2003.

Driessens G, Harsan L, Robaye B, Waroquier D, Browaeys P, Giannakopoulos X, Velu T, Bruyns C.
Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour.
Brit J Cancer 89, 727-729, 2003.

Dufour A, Seibt J, Passante L, Depaepe V, Ciossek T, Frisen J, Kullander K, Flanagan JG, Polleux F, Vanderhaeghen P.
Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes.
Neuron 39, 453-465, 2003.

El Housni H, Heimann P, Parma J, Vassart G.
Single-nucleotide polymorphism genotyping by melting analysis of dual- labeled probes: Examples using factor V Leiden and prothrombin 20210A mutations. Clin Chem 49, 1669-1672, 2003.

Giuriato S, Pesesse X, Bodin S, Sasaki T, Viala C, Marion E, Penninger J, Schurmans S, Erneux C, Payrastre B.
SH2 domain containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3, 4, 5-trisphosphate levels.
Biochem J 376, 199-207, 2003.

Govaerts C, Bondue A, Springael JY, Olivella M, Deupi X, Le Poul E, Wodak SJ, Parmentier M, Pardo L, Blanpain C.
Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3.
J Biol Chem 278, 1892-1903, 2003.

Jacobs C, Pirson I.
Pitfalls in the use of transfected overexpression systems to study membrane proteins function: the case of TSH receptor and PRA1.
Mol Cell Endocrinol 209, 71-75, 2003.

Marteau F, Le Poul E, Communi D, Communi D, Labouret C, Savi P, Boeynaems JM, Suarez-Gonzalez N.
Pharmacological characterization of the human P2Y13 receptor.
Mol Pharmacol 64, 104-112, 2003.

Panneels V, Schussler U, Costagliola S, Sinning I.
Choline head groups stabilize the matrix loop regions of the ATP/ADP carrier ScAAC2.
Biochem Biophys Res Commun 300, 65-74, 2003.

Paternot S, Coulonval K, Dumont JE, Roger PP.
Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
J Biol Chem 278, 26533-26540, 2003.

Pouillon V, Hascakova-Bartova R, Pajak B, Adam E, Bex F, Dewaste V, Van Lint C, Leo O, Erneux C, Schurmans S.
Inositol 1, 3, 4, 5-tetrakisphosphate is essential for T lymphocyte development.
Nature Immunol 4, 1136-1143, 2003.

Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart G, Pardo L, Costagliola S.
Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity.
EMBO J 22, 2692-2703, 2003.

Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S.
Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor.
New Engl J Med 349, 760-766, 2003.

Van Sande J, Costa MJ, Massart C, Swillens S, Costagliola S, Orgiazzi J, Dumont JE.
Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cells.
J Clin Endocrinol Metab 88, 5366-5374, 2003.

Vandenbroere I, Paternotte N, Dumont JE, Erneux C, Pirson I.
The c-Cbl-associated protein and c-Cbl are two new partners of the SH2-containing inositol polyphosphate 5-phosphatase SHIP2.
Biochem Biophys Res Commun 300, 494-500, 2003.

Vandeput F, Perpete S, Coulonval K, Lamy F, Dumont JE.
Role of the different mitogen-activated protein kinase subfamilies in the stimulation of dog and human thyroid epithelial cell proliferation by cyclic adenosine 5 '-monophosphate and growth factors.
Endocrinology 144, 1341-1349, 2003.

Vilain C, Libert F, Venet D, Costagliola S, Vassart G.
Small amplified RNA-SAGE: an alternative approach to study transcriptome from limiting amount of mRNA.
Nucl Acids Res 31, 2003.

Willermain F, Cabay L, Stordeur P, Blero D, Driessens G, Caspers-Velu L, Velu T, Bruyns C.
PPAR gamma agonist 15 prostaglandin J2 modulates inflammatory response on human retinal pigment epithelial cells.
Invest Ophthalmol Visual Sci 44, U219, 2003.

Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brezillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D.
Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids.
J Exp Med 198, 977-985, 2003.

 

Bruxelles capitale      EMBO      ERC      FNRS       HFSP       Region Wallonne        Télévie        fondation pour le cancer